Key facts
- It has raised $56.5M; the latest was PE Growth/Expansion ($31.3M) in Sep 2025.
- Notable investors include EGS Beteiligungen, Gimv.
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Spineart
- ·The full record, as it builds
Funding rounds
No funding rounds for Spineart are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Spineart
Manufacturer of surgical products intended to serve spine surgeons, operating room teams, and patients. The company offers patented and clinically validated technologies and products in the fields of minimally invasive surgery, motion preservation, fusion, biologics, and fracture treatment, thereby providing efficient and cost-effective services and reducing workflow complexity while increasing safety.
- Sector
- Healthcare
- HQ
- Geneva, Switzerland
- Founded
- 2005
- Employees
- 360
- Website
- spineart.com/
- Ownership
- Privately Held (backing)
Spineart doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Spineart shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Spineart in its N-PORT filings yet. We sweep new filings monthly.